Foundation for Addie’s Research Joins Oncoheroes To Create More and Better Options for Children Fighting Cancer
Every year near 100,000 kids worldwide die of cancer, largely because of the lack of innovative treatments for the types of cancer affecting children and adolescents. Oncoheroes Biosciences, has built a multi-asset portfolio of drugs to potentially treat several types of childhood cancer that have had little significant improvement over the past 20-30 years in overall survival.
“We are passionate about cancer research combined with a sense of urgency. We have been researching Oncoheroes’ lead compound, volasertib, for several years and feel confident in its efficacy”, said Christina Stiverson, President of the Foundation for Addie’s Research. “The foundation is extremely excited to support Oncoheroes moving volasertib into a clinical trial to create more and better options for children fighting cancer. This effort could have made a difference for my daughter Addie who ran out of available treatments”.
Credit: Oncoheroes, 06/16/22